Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-24-000035
Filing Date
2024-09-03
Accepted
2024-09-03 16:27:44
Documents
1
Period of Report
2024-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725395257.html 4  
1 FORM 4 wk-form4_1725395257.xml 4 3043
  Complete submission text file 0001739614-24-000035.txt   4620
Mailing Address C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK NY 10011
Business Address
Vuori Kristiina MD (Reporting) CIK: 0001612627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241274466

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)